QQ客服 官方微博 反馈留言

	Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
	Wang, Zhijie; Duan, Jianchun; Cai, Shangli; Han, Miao; Dong, Hua; Zhao, Jun; Zhu, Bo; Wang, Shuhang; Zhuo, Minglei; Sun, Jianguo
	2019
卷号	5期号:5页码:696-702
ISSN号	2374-2437
DOI	10.1001/jamaoncol.2018.7098
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6344135
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Wang, Zhijie,Duan, Jianchun,Cai, Shangli,et al. Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel[J],2019,5(5):696-702.
APA	Wang, Zhijie.,Duan, Jianchun.,Cai, Shangli.,Han, Miao.,Dong, Hua.,...&Wang, Jie.(2019).Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel.,5(5),696-702.
MLA	Wang, Zhijie,et al."Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel".5.5(2019):696-702.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。